Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Clinical trial NCT01572181 · COMPLETED
Trial details
- NCT number
- NCT01572181
- Sponsor
- Nantes University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2017-10-24
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.